scholarly journals CemoMemo

2021 ◽  
Vol 14 (4) ◽  
pp. 1-22
Author(s):  
Michael J. May ◽  
Efrat Kantor ◽  
Nissim Zror

Digitizing cemeteries and gravestones aids cultural preservation, genealogical search, dark tourism, and historical analysis. CemoMemo, an app and associated website, enables bottom-up crowd-sourced digitization of cemeteries, categorizing and indexing of gravestone data and metadata, and offering powerful full-text and numerical search. To date, CemoMemo has nearly 5,000 graves from over 130 cemeteries in 10 countries with the majority being Jewish graves in Israel and the USA. We detail CemoMemo's deployment and component models, technical attributes, and user models. CemoMemo went through two design iterations and architectures. We detail its initial architecture and the reasons that led to the change in architecture. To show its utility, we use CemoMemo's data for a historical analysis of two Jewish cemeteries from a similar period, eliciting cultural and ethnological difference between them. We present lessons learned from developing and operating CemoMemo for over 1 year and point to future directions of development.

2021 ◽  
pp. 0957154X2110346
Author(s):  
Tyler Durns

Involuntary hospitalization has been a fundamental function of psychiatric care for mentally ill persons in the USA for centuries. Procedural and judicial practices of inpatient psychiatric treatment and civil commitment in the USA have served as a by-product of socio-political pressures that demanded constant reform throughout history. The origin of modern commitment laws can best be understood through the lens of cultural paradigms that led to their creation and these suggest caution for future legislative amendments.


2020 ◽  
Vol 23 (2) ◽  
pp. 159-161 ◽  
Author(s):  
Erica Wilson ◽  
Rachelle Bernacki ◽  
Joshua R. Lakin ◽  
Corinne Alexander ◽  
Vicki Jackson ◽  
...  

2016 ◽  
Vol 11 (2) ◽  
pp. 61-64 ◽  
Author(s):  
Kenneth D. Ward

Treating tobacco dependence is paramount for global tobacco control efforts, but is often overshadowed by other policy priorities. As stated by Jha (2009), “cessation by current smokers is the only practical way to avoid a substantial proportion of tobacco deaths worldwide before 2050.” Its importance is codified in Article 14 of the Framework Convention on Tobacco Control (FCTC), and in the WHO's MPOWER package of effective country-level policies. Unfortunately, only 15% of the world's population have access to appropriate cessation support (WHO, 2015). Moreover, parties to the FCTC have implemented only 51% of the indicators within Article 14, on average, which is far lower than many other articles (WHO, 2014). Further, commenting on the use of “O” measures (Offer help to quit tobacco use) in the MPOWER acronym, WHO recently concluded, “while there has been improvement in implementing comprehensive tobacco cessation services, this is nonetheless a most under-implemented MPOWER measure in terms of the number of countries that have fully implemented it” (WHO, 2015). To the detriment of global tobacco control efforts, only one in eight countries provides comprehensive cost-covered services, only one in four provide some cost coverage for nicotine replacement therapy, and fewer than one third provide a toll-free quit line (WHO, 2015).


2003 ◽  
Vol 37 ◽  
pp. S107-S112 ◽  
Author(s):  
Joel Gittelsohn ◽  
Sally M Davis ◽  
Allan Steckler ◽  
Becky Ethelbah ◽  
Theresa Clay ◽  
...  

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Helen Mary Meldrum

PurposeThe overwhelming frequency of failure in trying to bring a safe and effective biotech, pharmaceutical or medical device product to market is truly astounding. This research synthesizes industry leaders' insights on lessons learned from reflecting on professional disappointments.Design/methodology/approachThis research used a qualitative approach to learning from the Chief Executive Officers (CEOs), Chief Scientific Officers (CSOs) and Chief Medical Officers (CMOs) of the most successful life science firms in the USA. A total of 45 industry leaders were interviewed regarding their lingering regrets about their career misadventures.FindingsRegrets were unavoidable because there were opportunity costs for every choice each leader made. Commentary about wisdom gained comprised themes regarding valuable time lost, strategies that could have been enacted, products that failed and essential personnel who were not managed optimally. Contrary to expectations, there was little mention of money that was squandered.Originality/valueNot felt as a solely negative emotion, regrets were recognized by these leaders as a potentially positive influence on their future decisions. Not felt as a solely negative emotion, regret was recognized by these leaders as a potentially positive influence on their future decisions. This exploratory study suggests that learning from retrospective and anticipated regrets benefits life science leaders in gaining clarity of thought regarding their current business challenges. Because prior research on the value of psychological regrets has mostly relied on limited samples, this inquiry contributes a new vantage point by examining a unique population of senior business leaders, thus providing broader applicability to the organizational literature.


Sign in / Sign up

Export Citation Format

Share Document